Prevalence of hypertension and cardiovascular risk factors among long-term AIDS survivors: A report from the field.


Journal

Journal of clinical hypertension (Greenwich, Conn.)
ISSN: 1751-7176
Titre abrégé: J Clin Hypertens (Greenwich)
Pays: United States
ID NLM: 100888554

Informations de publication

Date de publication:
10 2019
Historique:
received: 02 02 2019
revised: 14 05 2019
accepted: 18 06 2019
pubmed: 27 8 2019
medline: 22 10 2020
entrez: 27 8 2019
Statut: ppublish

Résumé

HIV infection is associated with increased risk and progression of cardiovascular disease (CVD), yet little is known about the prevalence of CVD risk factors among long-term AIDS survivors in resource-limited settings. Using routinely collected data, we conducted a retrospective study to describe the prevalence of CVD risk factors among a cohort of HIV-infected patients followed for over 10 years in Port-au Prince, Haiti. This cohort includes 910 adults who initiated antiretroviral therapy (ART) between 2003 and 2004 and remained in care between 2014 and 2016 when routine screening for CVD risk factors was implemented at a large clinic in Haiti. A total of 397 remained in care ≥10 years and received screening. At ART initiation, 59% were female, median age was 38 years (IQR 33-44), and median CD4 count was 117 cells/mm

Identifiants

pubmed: 31448551
doi: 10.1111/jch.13663
pmc: PMC6896990
mid: NIHMS1044686
doi:

Substances chimiques

Anti-Retroviral Agents 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1558-1566

Subventions

Organisme : FIC NIH HHS
ID : D43 TW009337
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL143788
Pays : United States
Organisme : FIC NIH HHS
ID : R25 TW009337
Pays : United States
Organisme : NIAID NIH HHS
ID : UM1 AI069421
Pays : United States

Informations de copyright

©2019 Wiley Periodicals, Inc.

Références

Arq Bras Cardiol. 2010 Oct;95(5):640-7
pubmed: 20963309
Stat Med. 2011 Feb 20;30(4):377-99
pubmed: 21225900
PLoS One. 2016 Feb 10;11(2):e0148100
pubmed: 26862763
Lancet. 2018 Nov 10;392(10159):1683
pubmed: 30415747
Am J Hypertens. 2014 Feb;27(2):222-8
pubmed: 24077828
Glob J Health Sci. 2013 Dec 01;6(2):58-71
pubmed: 24576366
J Infect Dis. 2003 Jun 15;187(12):1924-33
pubmed: 12792869
Int J Epidemiol. 2013 Dec;42(6):1754-71
pubmed: 24415610
Trans R Soc Trop Med Hyg. 2011 Nov;105(11):644-9
pubmed: 21924753
SAHARA J. 2018 Dec;15(1):110-120
pubmed: 30200815
J Acquir Immune Defic Syndr. 2015 Feb 1;68(2):209-16
pubmed: 25588033
Clin Infect Dis. 2014 Dec 15;59(12):1787-97
pubmed: 25182245
Am J Clin Nutr. 2011 Dec;94(6):1690S-1696S
pubmed: 22089433
J Acquir Immune Defic Syndr. 2008 Aug 15;48(5):629-31
pubmed: 18665025
BMC Med. 2014 Jul 29;12:125
pubmed: 25070128
N Engl J Med. 2005 Dec 1;353(22):2325-34
pubmed: 16319381
Medicine (Baltimore). 2018 Aug;97(35):e12121
pubmed: 30170445
Am J Med. 1991 Feb;90(2):154-62
pubmed: 1996584
Global Health. 2010 Apr 19;6:5
pubmed: 20403167
Pan Afr Med J. 2017 May 15;27:40
pubmed: 28761616
JAMA. 2014 Feb 5;311(5):507-20
pubmed: 24352797
Curr HIV/AIDS Rep. 2013 Sep;10(3):199-206
pubmed: 23793823
N Engl J Med. 2009 Aug 20;361(8):828-9
pubmed: 19692699
Rev Bras Enferm. 2017 Nov-Dec;70(6):1309-1317
pubmed: 29160495
Hypertension. 2018 Jul;72(1):44-55
pubmed: 29776989
Heart. 2016 Aug 1;102(15):1200-5
pubmed: 27105648
BMC Public Health. 2016 Dec 12;16(1):1243
pubmed: 27955664
N Engl J Med. 2016 Jan 28;374(4):397-8
pubmed: 26816026
Niger Med J. 2013 May;54(3):185-90
pubmed: 23901181
AIDS. 2018 Jul 1;32 Suppl 1:S43-S46
pubmed: 29952789
J Clin Hypertens (Greenwich). 2019 Oct;21(10):1558-1566
pubmed: 31448551
J Neurol Sci. 2019 Feb 15;397:103-111
pubmed: 30599299
J Clin Hypertens (Greenwich). 2013 Feb;15(2):101-6
pubmed: 23339727
PLoS One. 2011;6(7):e22288
pubmed: 21779407
J Am Soc Hypertens. 2015 May;9(5):351-7
pubmed: 25766497
BMC Public Health. 2016 Sep 21;16(1):1002
pubmed: 27655406
J Clin Endocrinol Metab. 2007 Jul;92(7):2506-12
pubmed: 17456578
Am J Med. 1993 May;94(5):515-519
pubmed: 7605397
HIV Med. 2006 Jan;7(1):10-5
pubmed: 16313287
Diabetes Metab. 2013 Feb;39(1):71-7
pubmed: 23153435
J Trop Med. 2012;2012:137460
pubmed: 23056058

Auteurs

Samuel Pierre (S)

Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.

Grace Seo (G)

Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Department of Medicine, Center for Global Health, Weill Cornell Medicine, New York, NY, USA.

Vanessa R Rivera (VR)

Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Department of Medicine, Center for Global Health, Weill Cornell Medicine, New York, NY, USA.

Kathleen F Walsh (KF)

Department of Medicine, Center for Global Health, Weill Cornell Medicine, New York, NY, USA.
Division of General Internal Medicine, Weill Cornell Medicine, New York, NY, USA.

Jean Joscar Victor (JJ)

Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.

Benedict Charles (B)

Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.

Gaetane Julmiste (G)

Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.

Emelyne Dumont (E)

Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.

Alexandra Apollon (A)

Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.

Molene Cadet (M)

Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.

Alix Saint-Vil (A)

Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.

Adias Marcelin (A)

Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.

Patrice Severe (P)

Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.

Myung Hee Lee (MH)

Department of Medicine, Center for Global Health, Weill Cornell Medicine, New York, NY, USA.

Justin Kingery (J)

Department of Medicine, Center for Global Health, Weill Cornell Medicine, New York, NY, USA.
Division of General Internal Medicine, Weill Cornell Medicine, New York, NY, USA.

Serena Koenig (S)

Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Daniel Fitzgerald (D)

Department of Medicine, Center for Global Health, Weill Cornell Medicine, New York, NY, USA.

Jean Pape (J)

Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Department of Medicine, Center for Global Health, Weill Cornell Medicine, New York, NY, USA.

Margaret L McNairy (ML)

Department of Medicine, Center for Global Health, Weill Cornell Medicine, New York, NY, USA.
Division of General Internal Medicine, Weill Cornell Medicine, New York, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH